Back to Search
MOHAMMED MAPARA, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1336285147Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
49590(CA)
Research & Publications (20)
Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
PMID 16737935·Biol Blood Marrow Transplant·2006
7-preclinical
Induction of mixed vs full chimerism to potentiate GVL effects after bone-marrow transplantation.
PMID 15585939·Methods Mol Med·2005
7-preclinical
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
PMID 15020616·J Clin Oncol·2004
6-review
Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
PMID 12883182·Transplantation·2003
7-preclinical
Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells.
PMID 12176915·Blood·2002
7-preclinical
Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
PMID 11787527·Biol Blood Marrow Transplant·2001
4-observational
Osteopetrosis with micro-lacunar resorption because of defective integrin organization.
PMID 19546854·Lab Invest·2009
8-other
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.
PMID 18566220·Mol Cancer Ther·2008
7-preclinical
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage.
PMID 17910628·Br J Haematol·2007
8-other
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.
PMID 17095620·Blood·2007
7-preclinical
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1.
PMID 16373662·Blood·2006
8-other
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.
PMID 16728283·Exp Hematol·2006
7-preclinical
9th Annual Meeting of the Regional Cancer Consortium for the Biological Therapy of Cancer. 16-18 February 2006, UPMC Herberman Conference Center, Pittsburgh, PA, USA.
PMID 16706609·Expert Opin Biol Ther·2006
7-preclinical
Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis.
PMID 15292067·Blood·2005
8-other
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
PMID 15598948·Ann Oncol·2005
3-trial
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
PMID 15939712·Ann Oncol·2005
3-trial
Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning.
PMID 14512313·Blood·2004
7-preclinical
Effective use of high-dose chemotherapy and autologous stem cell rescue for relapsed adult Wilms' tumor and a novel alteration in intron 1 of the WT1 gene.
PMID 15591903·J Pediatr Hematol Oncol·2004
5-case
Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.
PMID 15220955·Bone Marrow Transplant·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5814 RODEO RD
LOS ANGELES, CA 90016 - Phone
- (310) 836-7200
Quick Facts
- NPI
- 1336285147
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile